Inventor · disambiguated record
Pooran Chand
Also filed as: CHAND POORAN
34 granted patents·24 pending applications·866 citations·filing 1995–2024
98Inventor score
Files withBIOCRYST PHARM INC26BABU YARLAGADDA S9EIDOS THERAPEUTICS INC5ADVANCED CANCER THERAPEUTICS LLC3CLEM BRIAN2
Top patents by PatentIndex Score
58 records- 0198US7560434B2AZA nucleosides, preparation thereof and use as inhibitors of RNA viral polymerasesBIOCRYST PHARM INC·Filed 2005·Granted Jul 14, 2009·92 cites·29 claims
- 0297US7994139B2Antiviral therapeutic agentsBIOCRYST PHARM INC·Filed 2009·Granted Aug 9, 2011·81 cites·24 claims
- 0397US7429571B2Therapeutic furopyrimidines and thienopyrimidinesBIOCRYST PHARM INC·Filed 2006·Granted Sep 30, 2008·84 cites·16 claims
- 0496US8242085B2Tetrahydrofuro [3,4-D] dioxolane compounds for use in the treatment of viral infections and cancerBABU YARLAGADDA S·Filed 2008·Granted Aug 14, 2012·81 cites·46 claims
- 0596US7514410B2Hepatitis C therapiesBIOCRYST PHARM INC·Filed 2006·Granted Apr 7, 2009·80 cites·42 claims
- 0696US7388002B2Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerasesBIOCRYST PHARM INC·Filed 2005·Granted Jun 17, 2008·39 cites·16 claims
- 0795US8440813B2Antiviral nucleoside analogsBABU YARLAGADDA S·Filed 2008·Granted May 14, 2013·42 cites·1 claims
- 0895US8133870B2Therapeutic furopyrimidines and thienopyrimidinesBABU YARLAGADDA S·Filed 2005·Granted Mar 13, 2012·32 cites·24 claims
- 0995US6699994B1Biaryl compounds as serine protease inhibitorsBIOCRYST PHARM INC·Filed 2002·Granted Mar 2, 2004·87 cites·21 claims
- 1093US11078162B2Processes for preparing AG-10, its intermediates, and salts thereofEIDOS THERAPEUTICS INC·Filed 2019·Granted Aug 3, 2021·5 cites·54 claims
- 1192US8163703B2Hepatitis C therapiesBABU YARLAGADDA S·Filed 2009·Granted Apr 24, 2012·27 cites·31 claims
- 1290US11919865B2Processes for preparing AG-10, its intermediates, and salts thereofEIDOS THERAPEUTICS INC·Filed 2021·Granted Mar 5, 2024·1 cites·16 claims
- 1390US2025313534A1Processes for preparing ag-10, its intermediates, and salts thereofEIDOS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1489US10513497B2Process for preparing AG-10, its intermediates, and salts thereofEIDOS THERAPEUTICS INC·Filed 2018·Granted Dec 24, 2019·6 cites·10 claims
- 1589US6936719B2Biaryl compounds as serine protease inhibitorsBIOCRYST PHARM INC·Filed 2003·Granted Aug 30, 2005·37 cites·18 claims
- 1689US6503745B1Cyclopentane and cyclopentene compounds and use for detecting influenza virusBIOCRYST PHARM INC·Filed 1999·Granted Jan 7, 2003·42 cites·39 claims
- 1788US2024239751A1Processes for preparing ag-10, its intermediates, and salts thereofEIDOS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1887US5602277ASubstituted benzene derivatives useful as neuraminidase inhibitorsBIOCRYST PHARM INC·Filed 1995·Granted Feb 11, 1997·33 cites·25 claims
- 1985US8557823B2Family of PFKFB3 inhibitors with anti-neoplastic activitiesTAPOLSKY GILLES·Filed 2011·Granted Oct 15, 2013·18 cites·3 claims
- 2085US6518299B1Substituted pyrrolidine compounds useful as neuraminidase inhibitorsBIOCRYST PHARM INC·Filed 2000·Granted Feb 11, 2003·13 cites·1 claims
- 2183US6562861B1Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitorsBIOCRYST PHARM INC·Filed 1998·Granted May 13, 2003·31 cites·41 claims
- 2281US9770427B2Antiviral treatmentsBIOCRYST PHARM INC·Filed 2014·Granted Sep 26, 2017·3 cites·18 claims
- 2377US12121503B2Antiviral treatmentsBIOCRYST PHARM INC·Filed 2021·Granted Oct 22, 2024·0 cites·13 claims
- 2477US7230119B2Process for the preparation of substituted pyrrolidine derivatives and intermediatesBIOCRYST PHARM INC·Filed 2005·Granted Jun 12, 2007·2 cites·10 claims
- 2577US6762316B1Preparation of substituted cyclopentane and cyclopentene compounds and certain intermediatesBIOCRYST PHARM INC·Filed 2000·Granted Jul 13, 2004·9 cites·1 claims
- 2676US11464755B2Antiviral treatmentsBIOCRYST PHARM INC·Filed 2019·Granted Oct 11, 2022·0 cites·23 claims
- 2775US8778997B2Antiviral treatmentsBABU YARLAGADDA SUDHAKARA·Filed 2011·Granted Jul 15, 2014·3 cites·8 claims
- 2870US9403769B2Small molecule inhibitors of PFKFB3 and glycolytic flux and their methods of use as anti-cancer therapeuticsCHAND POORAN·Filed 2011·Granted Aug 2, 2016·2 cites·12 claims
- 2964US2024287089A1Preparation and Uses of 7-AzaindenoisoquinolinesPURDUE RESEARCH FOUNDATION·Filed 2024·Application pending·0 cites
- 3063US10010542B2PFKFB3 inhibit and methods of use as an anti-cancer therapeuticADVANCED CANCER THERAPEUTICS LLC·Filed 2017·Granted Jul 3, 2018·0 cites·11 claims
- 3161US7045535B2Compounds useful for inhibiting paramyxovirus neuraminidaseBIOCRYST PHARM INC·Filed 2002·Granted May 16, 2006·2 cites·14 claims
- 3260US2025074917A1Preparation and Uses of 7-AzaindenoisoquinolinesPURDUE RESEARCH FOUNDATION·Filed 2023·Application pending·0 cites
- 3360US2007203241A1Antiviral treatmentsBABU YARLAGADDA S·Filed 2007·Application pending·0 cites
- 3460US2018009764A1Method for treating macrophage migration inhibitory factor (mif)-implicated diseases and conditions with iodo pyrimidine derivativesUNIV LOUISVILLE RES FOUND INC·Filed 2017·Application pending·0 cites
- 3558US10391075B2Antiviral treatmentsBIOCRYST PHARMACEUTICALS·Filed 2017·Granted Aug 27, 2019·0 cites·21 claims
- 3658US6410594B1Substituted cyclopentane compounds useful as neuraminidase inhibitorsBIOCRYST PHARM INC·Filed 1997·Granted Jun 25, 2002·14 cites·31 claims
- 3758US2004014722A1Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerasesBIOCRYST PHARM INC·Filed 2003·Application pending·0 cites
- 3857US9162987B2Iodo pyrimidine derivatives useful for the treatment of macrophage migration inhibitory factor (MIF)-implicated diseases and conditionsMITCHELL ROBERT A·Filed 2010·Granted Oct 20, 2015·0 cites·5 claims
- 3956US2005033051A1Nucleosides preparation thereof and use as inhibitors of rna viral polymerasesFiled 2002·Application pending·0 cites
- 4055US9649305B2PFKFB3 inhibitor and methods of use as an anti-cancer therapeuticADVANCED CANCER THERAPEUTICS LLC·Filed 2013·Granted May 16, 2017·0 cites·17 claims
- 4155US2015368207A1Method for treating macrophage migration inhibitory factor (mif)-implicated diseases and conditions with iodo pyrimidine derivativesUNIV LOUISVILLE RES FOUND·Filed 2015·Application pending·0 cites
- 4255US2009247750A1Process for preparing nucleoside analogsBIOCRYST PHARM INC·Filed 2009·Application pending·0 cites
- 4355US2011144321A1Synthetic intermediates and processesBIOCRYST PHARM INC·Filed 2009·Application pending·0 cites
- 4454US9381172B2Small molecule choline kinase inhibitors, screening assays, and methods for treatment of neoplastic disordersCLEM BRIAN·Filed 2012·Granted Jul 5, 2016·0 cites·15 claims
- 4554US2004242599A1Cyclopentene nucleosides, preparation thereof and use as inhibitors of RNA viral polymerasesBIOCRYST PHARM INC·Filed 2004·Application pending·0 cites
- 4653US2011165183A1Piperidine derivatives as jak3 inhibitorsBIOCRYST PHARM INC·Filed 2009·Application pending·0 cites
- 4753US2012213735A1Therapeutic furopyrimidines and thienopyrimidinesBABU YARLAGADDA S·Filed 2012·Application pending·0 cites
- 4852US2013078218A1Hepatitis c therapiesBABU YARLAGADDA S·Filed 2012·Application pending·0 cites
- 4951US2007244193A1Intramuscular antiviral treatmentsBABU YARLAGADDA S·Filed 2006·Application pending·0 cites
- 5050US2004229839A1Substituted nucleosides, preparation thereof and use as inhibitors of RNA viral polymerasesBIOCRYST PHARM INC·Filed 2004·Application pending·0 cites
Showing the top 50 of 58 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Pooran Chand files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →